Role of Frailty in Assessing Eligibility for <scp>CAR</scp> T‐Cell Therapy in Haematology
An appropriate frailty assessment before CAR T-cell therapy promotes the productive use of resources and proper patient selection. Using a geriatric assessment and incorporating an assessment tool such as the CAR HEMATOTOX has the potential for assessing frail CAR T-cell therapy patients.
Authors
- Anthony W. Bannon
- Maura Dowling (ORCID: https://orcid.org/0000-0002-7832-6276)
- Jennifer Clesham (ORCID: https://orcid.org/0000-0002-5009-4901)
- Jacqueline McGrory
- D. R. Cox
Institutions
- Ollscoil na Gaillimhe – University of Galway (IE)
- University Hospital Galway (IE)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1111/ejh.70037
- Citations
- 1
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 1.05